Covers key innovations and global trends in biotech and pharma
CAR-T proved that engineered immune cells can transform cancer treatment. But most cancer targets remain hidden inside the cell—beyond CAR-T’s reach. Could TCR-T unlock these targets and become the next major platform for treating solid tumors?
CAR-T has changed cancer treatment—but it is also exposing the limits of today's healthcare payment systems. Why can a therapy be cost-effective yet still threaten insurance budgets? Explore how CAR-T is reshaping reimbursement, health economics, and the future of Cell & Gene Therapy.
CAR-T therapy redefined what a drug could be. By engineering immune cells into living medicines, CAR-T opened a new era of cell therapy. Here explains how CAR-T works, designs and drives innovation, understanding the science and its greatest challenges.
CAR-T therapy transformed cancer treatment, but scientific breakthroughs alone don't guarantee commercial success. Discover why manufacturing, supply chains, hospital capacity, and reimbursement became the real bottlenecks behind CAR-T commercialization.
Discover how GLP-1 drug revolutionized diabetes and weight-loss treatment. Learn the breakthrough discovery from Gila monster venom, and the evolution of marketed drugs from Exenatide to Semaglutide and Tirzepatide. Understand the science behind these game-changing medications.
